Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Total Non-Current Liabilities (2019 - 2022)

Pulmonx (LUNG) has disclosed Total Non-Current Liabilities for 3 consecutive years, with $38.7 million as the latest value for Q3 2022.

  • Quarterly Total Non-Current Liabilities changed N/A to $38.7 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $38.7 million through Sep 2022, changed N/A year-over-year, with the annual reading at $41.8 million for FY2021, N/A changed from the prior year.
  • Total Non-Current Liabilities for Q3 2022 was $38.7 million at Pulmonx, down from $40.4 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $240.9 million in Q4 2019, with the low at $38.7 million in Q3 2022.
  • Average Total Non-Current Liabilities over 3 years is $80.5 million, with a median of $40.5 million recorded in 2022.